![](https://monteverdelaw.com/wp-content/uploads/case-logo/la-jolla-pharmaceutical-co.jpg)
La Jolla Pharmaceutical Co. (LJPC), relating to its proposed acquisition by Innovia, Inc. Under the terms of the agreement, LJPC shareholders are expected to receive $6.23 in cash per share they own.
La Jolla Pharmaceutical Co. (LJPC), relating to its proposed acquisition by Innovia, Inc. Under the terms of the agreement, LJPC shareholders are expected to receive $6.23 in cash per share they own.